Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Megestrol Acetate for the Improvement of Quality of Life in Esophageal Cancer With Chemoradiotherapy

NCT02644408 is registered in ClinicalTrials.gov with The First Affiliated Hospital of Henan University of Science and Technology as lead sponsor.

NCT NCT02644408
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02644408 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Megestrol Acetate for the Improvement of Quality of Life in Esophageal Cancer With Chemoradiotherapy
Lead sponsor
The First Affiliated Hospital of Henan University of Science and Technology
Phase
Phase 3
Overall status
Completed
Start date
October 1, 2014
Completion date
December 1, 2020
Enrollment
184 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

stage ii esophageal squamous cell carcinoma, stage iii esophageal squamous cell carcinoma